NEWPORT BEACH, Calif., Oct. 11 /PRNewswire/ -- Each year, more than 90,000 U.S. women will be diagnosed with some form of gynecological cancer. Although the overall death rate for most of these cancers is falling, death from ovarian cancer has increased slightly.
Dr. Stan Wasbin, Medical Director of Your Cancer Today, (http://www.yourcancertoday.com) provides an overview of gynecological cancer, stressing the importance of early detection.
Your Cancer Today interviews Dr. Barbara Goff, Director of the Gynecologic Cancer Division at the University of Washington. Dr. Goff describes the risk factors and warning signs of endometrial, cervical and ovarian cancer. Dr. Goff reports that for the first time, professionals are identifying ovarian cancer symptoms and explains what women, and their doctors, should be on the alert for.
Treating brain cancer patients with a single drug often produces disappointing results. Your Cancer Today interviews Dr. Ronald A. DePinho, director of the Center for Applied Cancer Science at Dana-Farber Cancer Institute and professor of medicine at Harvard Medical School. Dr. DePinho recently completed a study-published in Science -- that suggested that many brain tumors should be genetically profiled and treated with multiple drugs.
Additional information from this week's episode:
-- When detected early, ovarian cancer usually can be cured. Yet most
cases are found late, when the 5-year survival rate is only 20-30%.
-- The oncologist's most successful screening test, the PAP smear, has
dropped the incidence of cervical cancer by more than 70%!
Dr. Goff discusses ovarian cancer symptoms
Dr. Ronald A. DePinho interview on his brain cancer s
|SOURCE Your Cancer Today|
Copyright©2007 PR Newswire.
All rights reserved